Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Osagie A. Eribo"'
Autor:
Osagie A. Eribo, Monkoe S. Leqheka, Stephanus T. Malherbe, Shirley McAnda, Kim Stanley, Gian D. van der Spuy, Gerhard Walzl, Novel N. Chegou
Publikováno v:
International Journal of Infectious Diseases, Vol 99, Iss , Pp 473-481 (2020)
Objective: To investigate the potential of host urinary biomarkers as diagnostic candidates for tuberculosis (TB). Methods: Adults self-presenting with symptoms requiring further investigation for TB were enrolled in Cape Town, South Africa. Particip
Externí odkaz:
https://doaj.org/article/1f3565bb92bc4774a06dcadb34b67091
Autor:
Osagie A. Eribo, Charissa C. Naidoo, Grant Theron, Gerhard Walzl, Nelita du Plessis, Novel N. Chegou
Publikováno v:
Microorganisms, Vol 11, Iss 2, p 451 (2023)
Bacteroides fragilis is a commonly investigated commensal bacterium for its protective role in host diseases. Here, we aimed to develop a reproducible antibiotic-based model for conditioning the gut microbiota and engrafting B. fragilis into a conven
Externí odkaz:
https://doaj.org/article/b0f8f5fe771b4feb85182b89443aea55
Publikováno v:
Infect Immun
The gut microbiota has emerged as a critical player in host health. Bacteroides fragilis is a prominent member of the gut microbiota within the phyla Bacteroidetes. This commensal bacterium produces unique capsular polysaccharides processed by antige
Autor:
Monkoe S. Leqheka, Stephanus T. Malherbe, Novel N. Chegou, Shirley McAnda, Gian D. van der Spuy, Kim Stanley, Gerhard Walzl, Osagie A. Eribo
Publikováno v:
International Journal of Infectious Diseases, Vol 99, Iss, Pp 473-481 (2020)
Objective To investigate the potential of host urinary biomarkers as diagnostic candidates for tuberculosis (TB). Methods Adults self-presenting with symptoms requiring further investigation for TB were enrolled in Cape Town, South Africa. Participan
Publikováno v:
Cellular and Molecular Life Sciences
Although tuberculosis (TB) is a curable disease, it remains the foremost cause of death from a single pathogen. Globally, approximately 1.6 million people died of TB in 2017. Many predisposing factors related to host immunity, genetics and the enviro